Halbach, M., Abraham, W. T., Butter, C., Ducharme, A., Klug, D., Little, W. C., … Müller-Ehmsen, J. (2018). Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease. International Journal of Cardiology, 266, 187–192. https://doi.org/10.1016/j.ijcard.2018.04.075

Halbach, Marcel, William T. Abraham, Christian Butter, Anique Ducharme, Didier Klug, William C. Little, Hannes Reuter, et al. “Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.” International Journal of Cardiology 266 (September 2018): 187–92. https://doi.org/10.1016/j.ijcard.2018.04.075.

Halbach M, Abraham WT, Butter C, Ducharme A, Klug D, Little WC, et al. Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease. International Journal of Cardiology. 2018 Sep;266:187–92.

Halbach, Marcel, et al. “Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.” International Journal of Cardiology, vol. 266, Elsevier BV, Sept. 2018, pp. 187–92. Crossref, doi:10.1016/j.ijcard.2018.04.075.

Halbach M, Abraham WT, Butter C, Ducharme A, Klug D, Little WC, Reuter H, Schafer JE, Senni M, Swarup V, Wachter R, Weaver FA, Wilks SJ, Zile MR, Müller-Ehmsen J. Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease. International Journal of Cardiology. Elsevier BV; 2018 Sep;266:187–192.